Influence of Azilsartan or Olmesartan on renin-angiotensin-aldosterone system.

Trial Profile

Influence of Azilsartan or Olmesartan on renin-angiotensin-aldosterone system.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 25 May 2017

At a glance

  • Drugs Azilsartan (Primary) ; Olmesartan medoxomil
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top